human Trx1, and glutathione reductase (GR), recombinant E.
coli Trx1, bovine glutathione peroxidase (GPx), insulin,
NADPH, 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB), APAP, NAPQI,
menadione (2-methyl-1,4-napthoquinone), reduced glutathione (GSH),
oxidized glutathione (GSSG), phosphatase inhibitors (catalog no. P2850,
which contains microcystinLR, cantharidin, and (−)-p-bromotetramisole), and protease inhibitor cocktail (catalog
no. P2714, which contains 4-(2-aminoethyl)benzenesulfonyl fluoride,
E-64, bestatin, leupeptin, aprotinin, and EDTA) were purchased from
Sigma-Aldrich (St. Louis, MO). Sodium aurothiomalate hydrate was from
Aldrich (Milwaukee, WI). Human recombinant TrxR mutant enzyme (Sec498Cys)
was from AbFrontier (Seoul, Korea). Pooled human liver microsomes
(HLM) and recombinant human P450s 1A2, 2E1, and 3A4 were purchased
from BD Genetest (Woburn, MA). N-(Biotinoyl)-N′-(iodoacetyl) ethylenediamine (BIAM) was from Molecular
Probes (Eugene, OR) and horseradish peroxidase (HRP)-conjugated streptavidin
from GE Healthcare (Piscataway, NJ). Enhanced chemiluminescence (ECL)
immunoblot detection reagents were from Thermo Scientific (Rockford,
IL).